Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly bioavailable extracts, today announced that its affiliate company, Protext Pharma, Inc. (TXTM), held a meeting July 4th 2018 at the company’s office in White River, Mpumalanga, with senior Government staff members of the South African Health Products Regulatory Authority (SAHPRA) (formerly known as the Medicine Control Council-MCC). The meetings included in-depth discussion of the company’s anticipated medical cannabis business in the country, site visit and complete inspection...
Read more
